Evidence map›Paper›PMID 26014643›Full record

ReviewThrombosis research2015

Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.

Brian R Branchford, Christopher J Ng, Keith B Neeves, Jorge Di Paola

Open access · greenAbstract readReview
In one paragraph

Review in Thrombosis research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Microfluidic Shear-Based Assay for Assessing ADAMTS13 Activity Under Flow.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Microfluidic devices for studying coagulation biology.Seminars in cell & developmental biology · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Getting a good view:Platelets · 2020
    Review
  20. Microfluidics in Haemostasis: A Review.Molecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Brian R BranchfordDept. of Pediatrics - Hematology/Oncology, University of Colorado School of Medicine, Aurora, CO, USA; University of Colorado Hemophilia and Thrombosis Center, Aurora, CO, USA.
Christopher J NgDept. of Pediatrics - Hematology/Oncology, University of Colorado School of Medicine, Aurora, CO, USA; University of Colorado Hemophilia and Thrombosis Center, Aurora, CO, USA.
Keith B NeevesDept. of Chemical & Biological Engineering, Colorado School of Mines, Golden, CO, USA.
Jorge Di PaolaDept. of Pediatrics - Hematology/Oncology, University of Colorado School of Medicine, Aurora, CO, USA; University of Colorado Hemophilia and Thrombosis Center, Aurora, CO, USA; Graduate Program- Human Medical Genetics and Genomics, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: jorge.dipaola@ucdenver.edu.
University of Colorado Denver · USColorado School of Mines · US

Funding

Training in Basic and Translational Child Health ResearchK12HD068372 · NICHD · UNIVERSITY OF COLORADO DENVER · PI DANIELS, STEPHEN R · 2011 to 2020
$3.7M
A Systems Biology Approach to Predicting Bleeding in HemophiliaR01HL120728 · NHLBI · COLORADO SCHOOL OF MINES · PI DI PAOLA, JORGE A, FOGELSON, AARON L · 2014 to 2018
$2.7M
Genetic Modifiers of von Willebrand DiseaseR01HL084086 · NHLBI · UNIVERSITY OF IOWA · PI DI PAOLA, JORGE A · 2007 to 2011
$1.7M
American Heart Association-American Stroke Association 14GRNT20410094NHLBI NIH HHS R01 HL084086NHLBI NIH HHS R01 HL120728NHLBI NIH HHS R01HL120728NICHD NIH HHS K12 HD068372NICHD NIH HHS K12HD068372-03
6 · The paper itself

Abstract

Assessment of platelet function and coagulation under flow conditions can augment traditional static assays used to evaluate patients with suspected hemostatic or thrombotic disorders. Among the available flow-based assays, microfluidic devices require the smallest blood volume and provide multiple output options. These assays are based on the presence of wall shear stress that mimics in vivo interactions between blood components and vessel walls. Microfluidic devices can generate essential information regarding homeostatic regulation of platelet activation and subsequent engagement of the coagulation cascade leading to fibrin deposition and clot formation. Emerging data suggest that microfluidic assays may also reveal consistent patterns of hemostatic or thrombotic pathology, and could aid in assessing and monitoring patient-specific effects of coagulation-modifying therapies.

Indexed as

HemostasisLab-On-A-Chip DevicesAnimalsAnticoagulantsBlood CoagulationBlood Coagulation TestsBlood PlateletsDrug MonitoringEquipment DesignHumansPlatelet Aggregation InhibitorsThrombosisAnticoagulantsPlatelet Aggregation Inhibitors

Identifiers

PMID26014643
PMCPMC4910695
OpenAlexW1936028382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.